The importance of hepatic functional reserve in sequential therapy with molecular targeted agents for advanced hepatocellular carcinoma １) Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and  candidates for regorafenib treatment in real-world practice 2) Trends in hepatic functional reserve of patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors

k8332_2

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k8332_2.pdf

https://hiroshima.repo.nii.ac.jp/record/2002790/files/k8332_2.pdf

ファイル	ライセンス
k8332_2.pdf (182.6 kB) sha256 cf9208475c1bc6b55e53ff07012d3c13a8466884c12b2179889365bdba3f9b35

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays